Codiak BioSciences files for Chapter 11 bankruptcy protection
27/03/2023 12:09
March 27 (Reuters) - Drug developer Codiak BioSciences Inc CDAK.O said on Monday it has filed for Chapter 11 bankruptcy protection and will seek to sell its assets, months after the company reduced its workforce by 37%. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shounak Dasgupta) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788))
Recent news on Codiak BioSciences,.
See all newsBrief: Codiak Biosciences Notice From Listing Qualifications Department Of Nasdaq Trading Of Co's Common Stock To Be Suspended At Opening Of Business On April 5
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
Codiak BioSciences down after co files for Chapter 11 bankruptcy